Difficulty: Medium
Average Score: 90%
Practice
A healthcare professional is reviewing a new prescription for Ondansetron 4 mg PO PRN for nausea and vomiting for a client who has Hyperemesis Gravidarum. The healthcare professional should clarify which of the following parts of the prescription with the provider?
Correct answer
D
Rationale
In this scenario, the healthcare professional should clarify the frequency part of the prescription with the provider. The correct answer is D) Frequency.
Rationale:
- Frequency refers to how often the medication should be taken. In this case, "PRN" (pro re nata) indicates that Ondansetron should be taken as needed for nausea and vomiting. However, it is crucial to establish clear parameters for when and how often the medication can be used to ensure proper management of Hyperemesis Gravidarum.
- A) Name: The name refers to the medication prescribed, which in this case is Ondansetron. Since the medication name is clear, there is no need to clarify this with the provider.
- B) Dosage: The dosage specified is 4 mg, which is a standard dose for Ondansetron. Unless there are specific concerns about the dosage in the context of pregnancy, there is no immediate need to clarify this with the provider.
- C) Route: The route specified is PO (by mouth), which is appropriate for oral medications. Given that the client is prescribed Ondansetron for oral use, there is no need to question the route with the provider.
Educational Context:
Understanding prescription components is essential for healthcare professionals to ensure safe and effective medication administration. In this case, clarifying the frequency of a PRN medication helps prevent under or overuse, especially in the context of managing conditions like Hyperemesis Gravidarum during pregnancy. By focusing on the frequency aspect, healthcare providers can optimize patient care and medication outcomes.
Rationale:
- Frequency refers to how often the medication should be taken. In this case, "PRN" (pro re nata) indicates that Ondansetron should be taken as needed for nausea and vomiting. However, it is crucial to establish clear parameters for when and how often the medication can be used to ensure proper management of Hyperemesis Gravidarum.
- A) Name: The name refers to the medication prescribed, which in this case is Ondansetron. Since the medication name is clear, there is no need to clarify this with the provider.
- B) Dosage: The dosage specified is 4 mg, which is a standard dose for Ondansetron. Unless there are specific concerns about the dosage in the context of pregnancy, there is no immediate need to clarify this with the provider.
- C) Route: The route specified is PO (by mouth), which is appropriate for oral medications. Given that the client is prescribed Ondansetron for oral use, there is no need to question the route with the provider.
Educational Context:
Understanding prescription components is essential for healthcare professionals to ensure safe and effective medication administration. In this case, clarifying the frequency of a PRN medication helps prevent under or overuse, especially in the context of managing conditions like Hyperemesis Gravidarum during pregnancy. By focusing on the frequency aspect, healthcare providers can optimize patient care and medication outcomes.